Sawada Akihisa, Koyama-Sato Maho, Yasui Masahiro, Kondo Osamu, Ishihara Takashi, Takeshita Yasufumi, Okamura Takayuki, Nishikawa Masanori, Inoue Masami, Kawa Keisei
Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
Pediatr Int. 2011 Dec;53(6):1010-7. doi: 10.1111/j.1442-200X.2011.03437.x.
Herpesviruses cause life-threatening diseases after hematopoietic stem cell transplantation (HSCT). It is necessary that viral diseases are identified early and safely diagnosed. The purpose of this study was to evaluate the efficacy of multiplex polymerase chain reaction (PCR) for qualitative detection of the six herpesviruses simultaneously: herpes simplex virus type 1 and type 2, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus (EBV) and human herpesvirus 6B.
Multiplex PCR was applied to patients with various clinical manifestations including central nervous system, cutaneous and mucosal complications after allogeneic HSCT, and the data were retrospectively analyzed.
Patients positive for cytomegalovirus in peripheral blood by multiplex PCR might need pre-emptive treatment, but a positive result for EBV had no specific correlation with EBV-associated post-transplant lymphoproliferative disease, and positive result for human herpesvirus 6B failed to show any clinical significance. The multiplex PCR was safe and helpful to diagnose viral diseases of local regions, for example, the central nervous system, skin and mucosa.
It may be worthwhile to survey the six herpesviruses with multiplex PCR after HSCT.
造血干细胞移植(HSCT)后疱疹病毒可引发危及生命的疾病。早期识别并安全诊断病毒性疾病很有必要。本研究旨在评估多重聚合酶链反应(PCR)同时定性检测六种疱疹病毒的效果,这六种病毒分别为1型和2型单纯疱疹病毒、水痘 - 带状疱疹病毒、巨细胞病毒、爱泼斯坦 - 巴尔病毒(EBV)和人类疱疹病毒6B。
对接受异基因HSCT后出现包括中枢神经系统、皮肤和黏膜并发症等各种临床表现的患者应用多重PCR,并对数据进行回顾性分析。
多重PCR检测外周血中巨细胞病毒呈阳性的患者可能需要进行抢先治疗,但EBV检测呈阳性与EBV相关的移植后淋巴细胞增生性疾病无特定关联,人类疱疹病毒6B检测呈阳性未显示出任何临床意义。多重PCR安全且有助于诊断局部区域的病毒性疾病,如中枢神经系统、皮肤和黏膜的疾病。
HSCT后用多重PCR检测这六种疱疹病毒可能是值得的。